BACKGROUND: Alterations in serum lipids and an increased risk of myocardial infarction have been associated with HIV-1 infection and its treatment. METHODS: Lipoprotein subclasses were measured by nuclear magnetic resonance spectroscopy in frozen plasma samples from participants in the Multicenter AIDS Cohort Study. The effects of HIV-1 infection, antiretroviral therapy, and other factors on median particle concentrations were examined using quantile regression. RESULTS: Fasted samples were tested from 1082 men, including 609 HIV-seronegative and 473 HIV-1-infected men. Compared with HIV-seronegative men, HIV-1-infected men on antiretroviral therapy had an atherogenic phenotype with higher numbers of very low density lipoprotein and small low-density lipoprotein particles and lower numbers of high-density lipoprotein and large low-density lipoprotein particles. HIV-infected, antiretroviral-naive men had significantly lower high-density lipoprotein and small low-density lipoprotein particle concentrations compared with the HIV-seronegative men. Among men on antiretroviral therapy, the atherogenic phenotype was most pronounced in men with a good clinical status. CONCLUSION: Use of antiretroviral therapy in HIV-1-infected men was associated with an "atherogenic lipoprotein phenotype."
BACKGROUND: Alterations in serum lipids and an increased risk of myocardial infarction have been associated with HIV-1 infection and its treatment. METHODS: Lipoprotein subclasses were measured by nuclear magnetic resonance spectroscopy in frozen plasma samples from participants in the Multicenter AIDS Cohort Study. The effects of HIV-1 infection, antiretroviral therapy, and other factors on median particle concentrations were examined using quantile regression. RESULTS: Fasted samples were tested from 1082 men, including 609 HIV-seronegative and 473 HIV-1-infectedmen. Compared with HIV-seronegative men, HIV-1-infectedmen on antiretroviral therapy had an atherogenic phenotype with higher numbers of very low density lipoprotein and small low-density lipoprotein particles and lower numbers of high-density lipoprotein and large low-density lipoprotein particles. HIV-infected, antiretroviral-naive men had significantly lower high-density lipoprotein and small low-density lipoprotein particle concentrations compared with the HIV-seronegative men. Among men on antiretroviral therapy, the atherogenic phenotype was most pronounced in men with a good clinical status. CONCLUSION: Use of antiretroviral therapy in HIV-1-infectedmen was associated with an "atherogenic lipoprotein phenotype."
Authors: Phyllis C Tien; Michael F Schneider; Christopher Cox; Mardge Cohen; Roksana Karim; Jason Lazar; Mary Young; Marshall J Glesby Journal: AIDS Date: 2010-11-27 Impact factor: 4.177
Authors: Jason Baker; Woubeshet Ayenew; Harrison Quick; Katherine Huppler Hullsiek; Russell Tracy; Keith Henry; Daniel Duprez; James D Neaton Journal: J Infect Dis Date: 2010-01-15 Impact factor: 5.226
Authors: Daniel A Duprez; Lewis H Kuller; Russell Tracy; James Otvos; David A Cooper; Jennifer Hoy; Jacqueline Neuhaus; Nicholas I Paton; Nina Friis-Moller; Fiona Lampe; Angelike P Liappis; James D Neaton Journal: Atherosclerosis Date: 2009-05-13 Impact factor: 5.162
Authors: Wen Guo; Siu Wong; Jeffrey Pudney; Ravi Jasuja; Ning Hua; Lan Jiang; Andrew Miller; Paul W Hruz; James A Hamilton; Shalender Bhasin Journal: Arterioscler Thromb Vasc Biol Date: 2009-09-17 Impact factor: 8.311
Authors: Matthew J Nicholaou; Jeremy J Martinson; Alison G Abraham; Todd T Brown; Shehnaz K Hussain; Steven M Wolinsky; Lawrence A Kingsley Journal: AIDS Res Hum Retroviruses Date: 2013-03-08 Impact factor: 2.205